Pacific Biosciences of California Aktie
1,41
EUR
+0,09
EUR
+7,21
%
1,65
USD
+0,11
USD
+7,17
%
Werbung
Pacific Biosciences of California Aktie Analyse
19.10.18 | Pacific Biosciences of California Outperform | Cowen and Company, LLC | |
03.11.17 | Pacific Biosciences of California Equal-Weight | First Analysis Securities | |
03.11.16 | Pacific Biosciences of California Buy | Cantor Fitzgerald | |
15.04.16 | Pacific Biosciences of California Overweight | First Analysis Securities | |
04.02.15 | Pacific Biosciences of California Buy | Maxim Group | |
17.03.11 | Pacific Biosciences of California perform | Oppenheimer & Co. Inc. |
Werbung
Werbung